Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Acro Biomedical (ACBM) Interest Coverage Ratio (2018 - 2025)

Acro Biomedical has reported Interest Coverage Ratio over the past 8 years, most recently at 42.47 for Q3 2025.

  • Quarterly results put Interest Coverage Ratio at 42.47 for Q3 2025, down 423.79% from a year ago — trailing twelve months through Dec 2025 was 25.56 (down 192.23% YoY), and the annual figure for FY2024 was 8.75, up 98.48%.
  • Interest Coverage Ratio for Q3 2025 was 42.47 at Acro Biomedical, down from 6.99 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for ACBM hit a ceiling of 8268.62 in Q4 2023 and a floor of 18940.44 in Q2 2022.
  • Median Interest Coverage Ratio over the past 5 years was 580.34 (2021), compared with a mean of 3781.41.
  • Biggest five-year swings in Interest Coverage Ratio: tumbled 82455.26% in 2022 and later skyrocketed 265.42% in 2023.
  • Acro Biomedical's Interest Coverage Ratio stood at 705.05 in 2021, then tumbled by 608.97% to 4998.59 in 2022, then skyrocketed by 265.42% to 8268.62 in 2023, then crashed by 100.1% to 7.86 in 2024, then crashed by 440.54% to 42.47 in 2025.
  • The last three reported values for Interest Coverage Ratio were 42.47 (Q3 2025), 6.99 (Q2 2025), and 6.54 (Q1 2025) per Business Quant data.